These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35091264)

  • 41. Direct Estimation of HDL-Mediated Cholesterol Efflux Capacity from Serum.
    Kuusisto S; Holmes MV; Ohukainen P; Kangas AJ; Karsikas M; Tiainen M; Perola M; Salomaa V; Kettunen J; Ala-Korpela M
    Clin Chem; 2019 Aug; 65(8):1042-1050. PubMed ID: 30996052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
    Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
    J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Patterns of Extreme and Persistent Cholesterol Efflux Capacity.
    El-Ghazali A; Deodhar S; Saldanha S; Smyth B; Izbrand M; Gangwar A; Pahlavani M; Rohatgi A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2588-2597. PubMed ID: 34433296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis.
    Qiu C; Zhao X; Zhou Q; Zhang Z
    Lipids Health Dis; 2017 Nov; 16(1):212. PubMed ID: 29126414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interrelationship among tobacco consumption, high-density lipoprotein cholesterol and leukocyte counts.
    Celada MM; Reguero JR; Cubero GI
    J Cardiovasc Risk; 1997 Aug; 4(4):279-81. PubMed ID: 9477206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammatory status and uricaemia determine HDL-cholesterol levels in hypertensive adults over 65: an analysis of the FAPRES register.
    Quintanilla MA; Andrés M; Pascual E; Pallarés V; Fácila L; Morillas P;
    Rheumatol Int; 2017 Jun; 37(6):941-948. PubMed ID: 28293775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The particular interactions of the traditional cardiovascular risk factors with different circulating specific leukocyte subtype counts in blood: an observational study.
    Kocaman SA; Sahinarslan A; Kunak T; Balcioğlu S; Cetin M; Cemri M; Timurkaynak T; Boyaci B; Cengel A
    Anadolu Kardiyol Derg; 2011 Nov; 11(7):573-81. PubMed ID: 21911321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
    Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis.
    Mackey RH; Mora S; Bertoni AG; Wassel CL; Carnethon MR; Sibley CT; Goff DC
    Diabetes Care; 2015 Apr; 38(4):628-36. PubMed ID: 25592196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Compared to serum triglyceride alone, the association between serum triglyceride to high-density lipoprotein cholesterol ratio and 10-year cardiovascular disease risk as determined by Framingham risk scores in a large Korean cohort.
    Lee HR; Kim JK; Kim JH; Chung TH
    Clin Chim Acta; 2021 Sep; 520():29-33. PubMed ID: 34058221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women.
    Greco D; Kocyigit D; Adorni MP; Marchi C; Ronda N; Bernini F; Gurses KM; Canpinar H; Guc D; Oguz SH; Gurlek A; Strazzella A; Simonelli S; Tokgozoglu L; Zimetti F
    Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):822-829. PubMed ID: 29954641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation.
    Minami-Takano A; Iwata H; Miyosawa K; Shiozawa T; Hayashi H; Funamizu T; Ishii K; Nozaki Y; Tabuchi H; Sekita G; Shimada K; Sumiyoshi M; Nakazato Y; Daida H; Minamino T
    Sci Rep; 2021 Feb; 11(1):3547. PubMed ID: 33574408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome.
    Khan AA; Mundra PA; Straznicky NE; Nestel PJ; Wong G; Tan R; Huynh K; Ng TW; Mellett NA; Weir JM; Barlow CK; Alshehry ZH; Lambert GW; Kingwell BA; Meikle PJ
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):438-447. PubMed ID: 29284607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants.
    Rhainds D; Tardif JC
    Curr Opin Lipidol; 2019 Apr; 30(2):101-107. PubMed ID: 30672808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.
    Ronsein GE; Hutchins PM; Isquith D; Vaisar T; Zhao XQ; Heinecke JW
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):404-11. PubMed ID: 26681752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.
    Gille A; D'Andrea D; Tortorici MA; Hartel G; Wright SD
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):953-963. PubMed ID: 29437574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neutrophil/HDL-C, Lymphocyte/HDL-C and Monocyte/HDL-C in subjects with asymptomatic carotid atherosclerosis.
    Caimi G; Lo Presti R; Urso C; Brucculeri S; Carlisi M
    Clin Hemorheol Microcirc; 2024; 88(1):1-11. PubMed ID: 38758993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of HDL Cholesterol Removal Capacity: Toward Clinical Application.
    Toh R
    J Atheroscler Thromb; 2019 Feb; 26(2):111-120. PubMed ID: 30542002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study.
    Quispe R; Manalac RJ; Faridi KF; Blaha MJ; Toth PP; Kulkarni KR; Nasir K; Virani SS; Banach M; Blumenthal RS; Martin SS; Jones SR
    Atherosclerosis; 2015 Sep; 242(1):243-50. PubMed ID: 26232164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol.
    Georgakis MK; Malik R; Anderson CD; Parhofer KG; Hopewell JC; Dichgans M
    Brain; 2020 Feb; 143(2):597-610. PubMed ID: 31968102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.